A randomized, double-blind, multi-center, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of subjects with knee osteoarthritis
Phase of Trial: Phase III
Latest Information Update: 11 Jun 2016
At a glance
- Drugs Calcitonin (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Nordic Bioscience
- 13 Jun 2015 Results (pooled analysis of CSMC021C2301 and CSMC021C2302) presented at the 16th Annual Congress of the European League Against Rheumatism.
- 10 Jun 2015 Post-hoc analysis (of trails NCT00486434 and NCT00704847) as per abstract presented at 16th Annual Congress of the European League Against Rheumatism.
- 05 Apr 2014 Post-hoc analysis for the CSMC021C2301 and CSMC021C2302 trials presented at the 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.